Determining Maximum Tolerated Dose in Elderly Clinical Trial Participants
Determining Maximum Tolerated Dose in Elderly Clinical Trial Participants How to Determine MTD Safely and Efficiently in Elderly Trial Participants Why Maximum Tolerated Dose Is Different in the Elderly Determining a maximum tolerated dose (MTD) in older adults is not a simple transplant of adult protocols into a geriatric population. Physiological changes that accompany aging—reduced…
Read More “Determining Maximum Tolerated Dose in Elderly Clinical Trial Participants” »